Literature DB >> 9414657

Mapping of a breast cancer tumor suppressor gene locus to a 4-cM interval on chromosome 18q21.

T Yokota1, S Matsumoto, M Yoshimoto, F Kasumi, F Akiyama, G Sakamoto, Y Nakamura, M Emi.   

Abstract

DPC4 and DCC, putative tumor suppressor genes implicated in the genesis of several types of human cancer, lie on the long arm of human chromosome 18. We examined 200 primary breast cancers for allelic losses on chromosome 18, using 15 microsatellite markers distributed along the long arm. Allelic loss was detected most frequently (29-30%) at loci mapped to 18q21. Deletion mapping of the 34 tumors showing partial or interstitial deletions identified a commonly deleted region within the 4-cM interval flanked by D18S474 and D18S487 at 18q21.1-q21.3. Although this interval included the DPC4 and DCC genes, we excluded DPC4 from candidacy when polymerase chain reaction-single-strand conformation polymorphism analysis of each exon failed to detect abnormalities in any of the 54 breast cancers that exhibited loss of heterozygosity involving 18q. Allelic loss on 18q was found more frequently in tumors of the solid tubular histological type (24 of 55, 44%) than in other types (24 of 113, 21%) (P = 0.0049). The results suggest that a tumor suppressor gene located within the 4-cM region at 18q21, either DCC or another gene not yet identified, may play a role in the development of some sporadic breast cancers, particularly those of the solid tubular type.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9414657      PMCID: PMC5921283          DOI: 10.1111/j.1349-7006.1997.tb00315.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  28 in total

1.  Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus.

Authors:  G Chenevix-Trench; J Leary; J Kerr; J Michel; R Kefford; T Hurst; P G Parsons; M Friedlander; S K Khoo
Journal:  Oncogene       Date:  1992-06       Impact factor: 9.867

2.  Accumulation of genetic alterations and progression of primary breast cancer.

Authors:  T Sato; F Akiyama; G Sakamoto; F Kasumi; Y Nakamura
Journal:  Cancer Res       Date:  1991-11-01       Impact factor: 12.701

3.  Report of the Third International Workshop on human chromosome 18 mapping 1995.

Authors:  J Overhauser; G A Silverman; S Gerken; A Geurts van Kessel
Journal:  Cytogenet Cell Genet       Date:  1995

4.  Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q.

Authors:  T Yamaguchi; J Toguchida; T Yamamuro; Y Kotoura; N Takada; N Kawaguchi; Y Kaneko; Y Nakamura; M S Sasaki; K Ishizaki
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

5.  The general rules for clinical and pathological recording of breast cancer. Japanese Breast Cancer Society.

Authors: 
Journal:  Jpn J Surg       Date:  1989-09

6.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

7.  Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alterations.

Authors:  Y Harada; T Katagiri; I Ito; F Akiyama; G Sakamoto; F Kasumi; Y Nakamura; M Emi
Journal:  Cancer       Date:  1994-10-15       Impact factor: 6.860

8.  Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma.

Authors:  M Shiseki; T Kohno; R Nishikawa; Y Sameshima; H Mizoguchi; J Yokota
Journal:  Cancer Res       Date:  1994-11-01       Impact factor: 12.701

9.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.

Authors:  T Sato; A Tanigami; K Yamakawa; F Akiyama; F Kasumi; G Sakamoto; Y Nakamura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

10.  Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.

Authors:  C S Cropp; R Lidereau; G Campbell; M H Champene; R Callahan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

View more
  8 in total

Review 1.  The role of estrogen in the initiation of breast cancer.

Authors:  J Russo; Irma H Russo
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12       Impact factor: 4.292

Review 2.  Transforming growth factor-beta and breast cancer: Transforming growth factor-beta/SMAD signaling defects and cancer.

Authors:  M Kretzschmar
Journal:  Breast Cancer Res       Date:  2000-02-21       Impact factor: 6.466

3.  Mapping of target regions of allelic loss in primary breast cancers to 1-cM intervals on genomic contigs at 6q21 and 6q25.3.

Authors:  Y Utada; S Haga; T Kajiwara; F Kasumi; G Sakamoto; Y Nakamura; M Emi
Journal:  Jpn J Cancer Res       Date:  2000-03

4.  Association of allelic losses at 3p25.1, 13q12, or 17p13.3 with poor prognosis in breast cancers with lymph node metastasis.

Authors:  S Haga; M Emi; A Hirano; Y Utada; T Kajiwara; F Akiyama; G Sakamoto; K Takahashi; T Tada; F Kasumi; Y Miki; Y Nakamura
Journal:  Jpn J Cancer Res       Date:  2001-11

5.  Cyclin E Overexpression in Human Mammary Epithelial Cells Promotes Epithelial Cancer-Specific Copy Number Alterations.

Authors:  Servando Giraldez; Pablo Tamayo; Nathan Wineinger; William Kim; Steven I Reed
Journal:  iScience       Date:  2019-08-27

6.  Frequent allelic loss at 7p14-15 associated with aggressive histologic types of breast cancer.

Authors:  K Kurose; A Iida; T Araki; G Sakamoto; F Kasumi; Y Nakamura; M Emi
Journal:  Jpn J Cancer Res       Date:  1998-05

7.  Allelic loss on chromosome 9q is associated with lymph node metastasis of primary breast cancer.

Authors:  K Minobe; M Onda; A Iida; F Kasumi; G Sakamoto; Y Nakamura; M Emi
Journal:  Jpn J Cancer Res       Date:  1998-09

8.  Increased Smad3 and reduced Smad2 levels mediate the functional switch of TGF-β from growth suppressor to growth and metastasis promoter through TMEPAI/PMEPA1 in triple negative breast cancer.

Authors:  Prajjal K Singha; Srilakshmi Pandeswara; Hui Geng; Rongpei Lan; Manjeri A Venkatachalam; Albert Dobi; Shiv Srivastava; Pothana Saikumar
Journal:  Genes Cancer       Date:  2019
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.